XACT Robotics
Tel Aviv, Israel· Est.
Robotic needle‑placement platform that enhances accuracy, consistency and efficiency for percutaneous interventions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $30M
AI Company Overview
Robotic needle‑placement platform that enhances accuracy, consistency and efficiency for percutaneous interventions.
OncologyPulmonaryHepatologyUrologyInterventional Radiology
Technology Platform
Proprietary S‑Drive robotic system that dynamically adjusts needle trajectories in real‑time to compensate for patient and target motion during percutaneous procedures.
Opportunities
Expansion into additional ablation indications, integration with emerging imaging modalities, and scaling commercial operations across North America and Europe.
Risk Factors
Regulatory approvals in new markets, physician adoption barriers, and competition from established robotic interventional platforms.
Competitive Landscape
Competitors include Medtronic's Mazor X, Intuitive Surgical's da Vinci for interventional use, and Corindus Vascular Robotics; XACT differentiates with its S‑Drive real‑time trajectory adjustment and patient‑mounted design.